Inventor
NEAGU CONSTANTIN
US18 patents
⚠️ This page may combine multiple inventors who share the name “NEAGU CONSTANTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
12 patentsUS10329270B2Jun 25, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH16 citations83
US9440968B2Sep 13, 2016
Substituted pyrido[3,2-d]pyrimidines for treating cancer
MERCK PATENT GMBH5 citations82
US10253023B2Apr 9, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH3 citations71
US9139568B2Sep 22, 2015
Heterocyclic carboxamides as modulators of kinase activity
MERCK PATENT GMBH4 citations71
US11098041B2Aug 24, 2021
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH1 citations61
US10080750B2Sep 25, 2018
Aminopyrimidine derivatives for use as modulators of kinase activity
MERCK PATENT GMBH1 citations61
US10233160B2Mar 19, 2019
Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
MERCK PATENT GMBH0 citations51
US10087166B2Oct 2, 2018
Cyclic amine azaheterocyclic carboxamides
MERCK PATENT GMBH0 citations51
US10080753B2Sep 25, 2018
Heterocyclic carboxamides as modulators of kinase activity
MERCK PATENT GMBH0 citations51
US9981925B2May 29, 2018
Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
MERCK PATENT GMBH0 citations51
US12415803B2Sep 16, 2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)
MERCK PATENT GMBH0 citations50
US9662330B2May 30, 2017
Aminopyrimidine derivatives for use as modulators of kinase activity
MERCK PATENT GMBH1 citations50